Consainsights logo
Life Sciences

Ophthalmic Drugs Market

Drug Class, Product Type.
License Type
What you get?
  • Online view only
  • Delivered in 24-72 hours
  • Only a single designated user can access the report
  • 5 hours of analyst support

Executive Summary

Ophthalmic Drugs Market from Consainsights analyses the Ophthalmic Drugs Market in the Technology & Media industry over the forecast period to 2026.

Ophthalmic Drugs research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Ophthalmic Drugs segmentation includes Drug Class, Product Type and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Drug Class, the Ophthalmic Drugs Market analysis covers Anti-glaucoma Drug, Anti-infective Drugs, Dry eye Drug, Ophthalmic Anti-allergy/Inflammatory, Other Drugs, Retinal Drug.

Based on the Product Type, the Ophthalmic Drugs Market analysis covers OTC Drug, Prescription Drug.

Key companies operating in the market include Bayer AG, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Santen Pharmaceutical Co. Ltd, Abbive (Allergan), Hoya Corporation, Bausch Health Companies Inc., Novartis AG, Aerie Pharmaceuticals Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Report Metric

Details

Market size available for years

2012-2027

Base year considered

2021

Forecast period

2022-2027

Forecast units

Value (USD Billion)

Segments covered

Drug Class, Product Type

Geographies covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Companies Covered

Bayer AG, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Santen Pharmaceutical Co. Ltd, Abbive (Allergan), Hoya Corporation, Bausch Health Companies Inc., Novartis AG, Aerie Pharmaceuticals Inc.


Table of Contents

  1. Executive Summary

  2. Ophthalmic Drugs Market Overview

    1. Ophthalmic Drugs Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Ophthalmic Drugs Market 360° Synopsis: Overview
  3. Ophthalmic Drugs Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Ophthalmic Drugs Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Ophthalmic Drugs Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Ophthalmic Drugs Market: Drug Class

    1. Introduction
    2. Anti-glaucoma Drug: Market Trends, Size, and Forecast (2017-2026)
    3. Anti-infective Drugs: Market Trends, Size, and Forecast (2017-2026)
    4. Dry eye Drug: Market Trends, Size, and Forecast (2017-2026)
    5. Ophthalmic Anti-allergy/Inflammatory: Market Trends, Size, and Forecast (2017-2026)
    6. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
    7. Retinal Drug: Market Trends, Size, and Forecast (2017-2026)
  6. Ophthalmic Drugs Market: Product Type

    1. Introduction
    2. OTC Drug: Market Trends, Size, and Forecast (2017-2026)
    3. Prescription Drug: Market Trends, Size, and Forecast (2017-2026)
  7. Global Analysis

    1. Global Ophthalmic Drugs Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  8. North America Analysis

    1. North America Ophthalmic Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States Ophthalmic Drugs Market: Drug Class
        3. United States Ophthalmic Drugs Market: Product Type
      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada Ophthalmic Drugs Market: Drug Class
        3. Canada Ophthalmic Drugs Market: Product Type
    2. North America Ophthalmic Drugs Market, By Drug Class, Y-O-Y Growth Analysis

      1. Introduction
      2. Anti-glaucoma Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Anti-infective Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Dry eye Drug: Market Trends, Size, and Forecast (2017-2026)
      5. Ophthalmic Anti-allergy/Inflammatory: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      7. Retinal Drug: Market Trends, Size, and Forecast (2017-2026)
    3. North America Ophthalmic Drugs Market, By Product Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drug: Market Trends, Size, and Forecast (2017-2026)
  9. Latin America Analysis

    1. Latin America Ophthalmic Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil Ophthalmic Drugs Market: Drug Class
        3. Brazil Ophthalmic Drugs Market: Product Type
      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina Ophthalmic Drugs Market: Drug Class
        3. Argentina Ophthalmic Drugs Market: Product Type
      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico Ophthalmic Drugs Market: Drug Class
        3. Mexico Ophthalmic Drugs Market: Product Type
      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia Ophthalmic Drugs Market: Drug Class
        3. Colombia Ophthalmic Drugs Market: Product Type
      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America Ophthalmic Drugs Market: Drug Class
        3. Rest of Latin America Ophthalmic Drugs Market: Product Type
    2. Latin America Ophthalmic Drugs Market, By Drug Class, Y-O-Y Growth Analysis

      1. Introduction
      2. Anti-glaucoma Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Anti-infective Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Dry eye Drug: Market Trends, Size, and Forecast (2017-2026)
      5. Ophthalmic Anti-allergy/Inflammatory: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      7. Retinal Drug: Market Trends, Size, and Forecast (2017-2026)
    3. Latin America Ophthalmic Drugs Market, By Product Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drug: Market Trends, Size, and Forecast (2017-2026)
  10. Asia-Pacific Analysis

    1. Asia-Pacific Ophthalmic Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China Ophthalmic Drugs Market: Drug Class
        3. China Ophthalmic Drugs Market: Product Type
      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan Ophthalmic Drugs Market: Drug Class
        3. Japan Ophthalmic Drugs Market: Product Type
      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India Ophthalmic Drugs Market: Drug Class
        3. India Ophthalmic Drugs Market: Product Type
      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia Ophthalmic Drugs Market: Drug Class
        3. Southeast Asia Ophthalmic Drugs Market: Product Type
      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand Ophthalmic Drugs Market: Drug Class
        3. Australia & New Zealand Ophthalmic Drugs Market: Product Type
      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific Ophthalmic Drugs Market: Drug Class
        3. Rest of Asia-Pacific Ophthalmic Drugs Market: Product Type
    2. Asia-Pacific Ophthalmic Drugs Market, By Drug Class, Y-O-Y Growth Analysis

      1. Introduction
      2. Anti-glaucoma Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Anti-infective Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Dry eye Drug: Market Trends, Size, and Forecast (2017-2026)
      5. Ophthalmic Anti-allergy/Inflammatory: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      7. Retinal Drug: Market Trends, Size, and Forecast (2017-2026)
    3. Asia-Pacific Ophthalmic Drugs Market, By Product Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drug: Market Trends, Size, and Forecast (2017-2026)
  11. Europe Analysis

    1. Europe Ophthalmic Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany Ophthalmic Drugs Market: Drug Class
        3. Germany Ophthalmic Drugs Market: Product Type
      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom Ophthalmic Drugs Market: Drug Class
        3. United Kingdom Ophthalmic Drugs Market: Product Type
      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France Ophthalmic Drugs Market: Drug Class
        3. France Ophthalmic Drugs Market: Product Type
      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain Ophthalmic Drugs Market: Drug Class
        3. Spain Ophthalmic Drugs Market: Product Type
      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia Ophthalmic Drugs Market: Drug Class
        3. Russia Ophthalmic Drugs Market: Product Type
      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy Ophthalmic Drugs Market: Drug Class
        3. Italy Ophthalmic Drugs Market: Product Type
      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe Ophthalmic Drugs Market: Drug Class
        3. Rest of Europe Ophthalmic Drugs Market: Product Type
    2. Europe Ophthalmic Drugs Market, By Drug Class, Y-O-Y Growth Analysis

      1. Introduction
      2. Anti-glaucoma Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Anti-infective Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Dry eye Drug: Market Trends, Size, and Forecast (2017-2026)
      5. Ophthalmic Anti-allergy/Inflammatory: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      7. Retinal Drug: Market Trends, Size, and Forecast (2017-2026)
    3. Europe Ophthalmic Drugs Market, By Product Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drug: Market Trends, Size, and Forecast (2017-2026)
  12. Middle East & Africa Analysis

    1. Middle East & Africa Ophthalmic Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East Ophthalmic Drugs Market: Drug Class
        3. Middle East Ophthalmic Drugs Market: Product Type
      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa Ophthalmic Drugs Market: Drug Class
        3. Africa Ophthalmic Drugs Market: Product Type
      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa Ophthalmic Drugs Market: Drug Class
        3. Rest of Middle East & Africa Ophthalmic Drugs Market: Product Type
    2. Middle East & Africa Ophthalmic Drugs Market, By Drug Class, Y-O-Y Growth Analysis

      1. Introduction
      2. Anti-glaucoma Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Anti-infective Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Dry eye Drug: Market Trends, Size, and Forecast (2017-2026)
      5. Ophthalmic Anti-allergy/Inflammatory: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      7. Retinal Drug: Market Trends, Size, and Forecast (2017-2026)
    3. Middle East & Africa Ophthalmic Drugs Market, By Product Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drug: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drug: Market Trends, Size, and Forecast (2017-2026)
  13. Ophthalmic Drugs Market: Company Analysis

    1. Introduction
    2. Bayer AG

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. Regeneron Pharmaceuticals Inc.

    4. F. Hoffmann-La Roche Ltd

    5. Pfizer Inc.

    6. Santen Pharmaceutical Co. Ltd

    7. Abbive (Allergan)

    8. Hoya Corporation

    9. Bausch Health Companies Inc.

    10. Novartis AG

    11. Aerie Pharmaceuticals Inc.

  14. Ophthalmic Drugs Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  15. Ophthalmic Drugs Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  16. Industry & Analysts Insights for Success

  17. Research Methodology

  18. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures & Tables

List of Figures

Figure: Global Ophthalmic Drugs Market: Structure

Figure: Global Ophthalmic Drugs Market: Value Chain Analysis

Figure: Global Ophthalmic Drugs Market: Porter's Five Forces Model

Figure: Global Ophthalmic Drugs Market: Market Dynamics

Figure: Global Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: North America Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: Europe Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: Asia-Pacific Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: Latin America Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: Middle East & Africa Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: Global Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: North America Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: Europe Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: Asia-Pacific Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: Latin America Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

Figure: Middle East & Africa Ophthalmic Drugs Market, By Ophthalmic Drugs, 2022-2027 (USD Million)

List of Tables

Table: Global Ophthalmic Drugs Market, By Drug Class, 2017-2026 (USD Million)

Table: North America Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: United States Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Canada Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Europe Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Germany Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: United Kingdom Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: France Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Spain Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Russia Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Italy Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Rest of Europe Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Asia-Pacific Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: China Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Japan Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: India Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Southeast Asia Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Australia & New Zealand Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Latin America Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Brazil Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Argentina Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Mexico Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Colombia Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Rest of Latin America Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Middle East & Africa Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Middle East Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Africa Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Ophthalmic Drugs Market, By Drug Class, 2022-2027 (USD Million)

Table: Global Ophthalmic Drugs Market, By Product Type, 2017-2026 (USD Million)

Table: North America Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: United States Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Canada Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Europe Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Germany Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: United Kingdom Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: France Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Spain Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Russia Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Italy Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Rest of Europe Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Asia-Pacific Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: China Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Japan Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: India Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Southeast Asia Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Australia & New Zealand Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Latin America Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Brazil Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Argentina Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Mexico Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Colombia Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Rest of Latin America Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Middle East & Africa Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Middle East Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Africa Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Ophthalmic Drugs Market, By Product Type, 2022-2027 (USD Million)